NRX Pharmaceuticals, Inc. (NRXP) Operating income 2018–2025
NRX Pharmaceuticals, Inc. (NRXP) annual operating income history from SEC filings — each fiscal year as reported.
-$16.2MFY2025 · since FY2018: -$1.0M → -$16.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$16.2M | +12.3% |
| FY2024 | -$18.5M | +33.5% |
| FY2023 | -$27.8M | +37.2% |
| FY2022 | -$44.3M | +61.7% |
| FY2021 | -$115.8M | -125.3% |
| FY2020 | -$51.4M | -7105.3% |
| FY2019 | -$713,187 | +29.1% |
| FY2018 | -$1.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice